FDA Import Refusal AEK-0299214-6/30002/1 — Intas Pharmaceuticals Limited
The FDA refused shipment AEK-0299214-6/30002/1 from Intas Pharmaceuticals Limited (India) on April 17, 2026. The refused product falls under Drugs and Biologics — TACROLIMUS (IMMUNOSUPPRESSIVE). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 17, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64TDY08 TACROLIMUS (IMMUNOSUPPRESSIVE)
- Charges
- 27